Solar Might Finally Have a Chance in the Energy Industry
| |

Solar Might Finally Have a Chance in the Energy Industry

Historically, solar has struggled to compete in the energy industry because fossil fuels and natural gas have always been cheaper. Only environmentally conscious people chose to invest in solar, and most did not see a return on their investment. However, a recent study by Deutsche Bank says things may turn around for solar by 2016.

UHC Announces the 2014 Supply Chain Performance Excellence Awards
| |

UHC Announces the 2014 Supply Chain Performance Excellence Awards

UHC is a research alliance for nonprofit academic medical centers around the nation. They conduct studies on the effiicency and quality of hospital supply chains. Since 2007, UHC has been giving awards to healthcare organizations with the best supply chain systems. They conduct a study each year and then present awards based on their findings….

Airbus’ Wide-Body A350 on the Tailwind of Boeing’s 787 With Its First Scheduled Delivery
| |

Airbus’ Wide-Body A350 on the Tailwind of Boeing’s 787 With Its First Scheduled Delivery

According to Bloomberg News, “Airbus Group NV (AIR)’s A350 jet landed at the company’s Toulouse base in southern France last night to end 14 months of trials that pave the way for the new model’s certification and first delivery later this year.”

Latest Numbers Indicated Slow But Steady U.S. Manufacturing Growth
| |

Latest Numbers Indicated Slow But Steady U.S. Manufacturing Growth

According to the Associated Press wire, “The U.S. economy already has been showing renewed strength. Economic growth clocked in an impressive 4 percent annual pace from April through June after getting off to a bad start the first three months of the year. And the Labor Department said Friday that employers added more than 200,000…

Companies Offer Ebola Solutions Despite Lack of Official Drug Manufacturing
| | |

Companies Offer Ebola Solutions Despite Lack of Official Drug Manufacturing

The ongoing Ebola epidemic in West Africa has brought on a global call for action. The message is being sent directly to pharma manufacturers. The issue remains: Currently, there is no medicine or vaccine that’s registered, let alone approved, to treat the deadly disease.